SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD — Progress Note 2 — Focused Visit (Follow-up) — Joe Louis — True-date frame: synthetic events are moved into the patient's historical lifetime. Codes, instruments, and treatments remain modern and are anachronistic.

PatientJoe Louis
Date of birth1914-05-13
IdentifiersMRN HR-BX002-SYN-TD; SSN (made up) 000-02-6639
Document date1969-07-20
AuthorDesmond Achterberg-Cole, MD
CustodianSt. Posthumous Health Center

Readable copy of the C-CDA narrative, generated with the XML. Coded entries are in the XML file beside this page.

Chief Complaint

One-week review of persecutory thoughts, seen the same day by addiction psychiatry. [S]

History of Present Illness

Mr. Louis returns one week after intake and is seen by Dr. Featherstone-Ibe of addiction psychiatry on the same day. He has used no cocaine since three days before his intake visit, ten days in all, and has kept his naloxone and test strips at home. The belief that people are following him and plan to harm him is less intense but still there; he checks the street from his window several times a night and sleeps about four hours. He has had no hallucinations and no thoughts of harming himself or anyone else, and he has not confronted anyone. The phone check three days after intake found him safe. The intake urine test, done with his consent, was positive for cocaine and negative for fentanyl, other opioids, amphetamines, benzodiazepines and cannabis. HIV, hepatitis C and syphilis tests were negative; he is not infected with hepatitis B and is not immune. His thyroid and vitamin B12 tests were normal. His brain MRI this morning showed no contusion, microbleeds or other abnormality. He wants to get well and agreed to the specialist plan. [S]

ElementDetail
Last cocaine useTen days ago
Persecutory beliefsPresent, less intense; partial insight
SleepAbout four hours
Intake resultsUrine positive for cocaine, negative for fentanyl and other drugs; HIV, hepatitis C and syphilis negative; hepatitis B not immune; TSH and B12 normal
Brain MRINormal for age

Review of Systems

SystemResultFinding
ConstitutionalPositiveTired from short sleep; appetite normal
CardiovascularNegativeNo chest pain or palpitations since the collapse
NeurologicalNegativeNo headache, weakness or numbness
PsychiatricPositivePersecutory beliefs persist; no hallucinations; no thoughts of suicide or of harming anyone

4 systems reviewed. [S]

Medications

MedicationFrequencyRouteDatesStatusEvidence
Naloxone 4 mg nasal spray, one spray into one nostril for a suspected opioid overdose, repeated every two to three minutes in the other nostril if needed; two-pack dispensed, with fentanyl test strips and instruction for him and anyone he lives withOne spray as needed for suspected overdose; repeat in 2 to 3 minutes if neededNasal route1969-07-13activeS
Aripiprazole 5 mg oral tablet, one tablet each morningOne tablet each morningOral route1969-07-20 to 1969-09-21completedS

Allergies and Intolerances

AllergyReactionStatusEvidence
No known allergyactiveS

Vital Signs

DateMeasureValueUnitProvenance
1969-07-20Body height187cmS
1969-07-20Body weight101kgS
1969-07-20Body mass index (BMI) [Ratio]28.9kg/m2S
1969-07-20Systolic blood pressure148mm[Hg]S
1969-07-20Diastolic blood pressure94mm[Hg]S
1969-07-20Heart rate90/minS
1969-07-20Respiratory rate16/minS
1969-07-20Body temperature36.8CelS
1969-07-20Oxygen saturation in Arterial blood by Pulse oximetry98%S

Results

DateMeasureValueUnitReference rangeFlagProvenance
1969-07-20Cholesterol [Mass/volume] in Serum or Plasma204mg/dL<=199 mg/dLHighS
1969-07-20Cholesterol in HDL [Mass/volume] in Serum or Plasma44mg/dL>=40 mg/dLNormalS
1969-07-20Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation128mg/dL<=99 mg/dLHighS
1969-07-20Triglyceride [Mass/volume] in Serum or Plasma160mg/dL<=149 mg/dLHighS

Physical Exam

Vital signs recorded on 1969-07-20; see the Vital Signs section. [S]

SystemFinding
GeneralAlert; blood pressure 148/94, pulse 90; weight 101.0 kg
Ears, nose, mouth, and throatNasal septum intact
NeurologicalCranial nerves normal; no tremor, rigidity or abnormal movements (AIMS 0); gait normal
PsychiatricCourteous and watchful; persecutory delusion held less firmly than a week ago; no hallucinations; oriented; no suicidal or homicidal ideation

Problems

ProblemClinical statusVerificationCodeProvenance
Persecutory thoughts and poor sleep for about two months: a fixed belief that people are following him and plan to harm him, three to four hours of sleep a night, partial insight; cause under evaluationresolvedconfirmed R41.89S — Synthetic presenting problem anchored to his documented fears of a plot against his life; resolved into the diagnosis at the consultation. Not a claim about his real symptoms.
Cocaine use disorder, severe (seven of eleven DSM-5-TR criteria): intranasal cocaine most days for about a year, last use three days before intakeresolvedconfirmed F14.20S — Synthetic modern coding at intake; superseded at the consultation by the combined code once the psychotic disorder was diagnosed. Person-first language; not a claim about his real diagnosis.
Cocaine use disorder, severe, with cocaine-induced psychotic disorder (persecutory delusions during heavy use, persisting ten days after the last use, with no history of psychosis off cocaine, a normal examination and no evidence of a neurocognitive disorder); psychotic symptoms resolved within four weeks on aripiprazoleactiveconfirmed F14.250S — Synthetic modern diagnosis made at the consultation. Not a claim about his real diagnosis.
Raised blood pressure at intake (154/98 mmHg) three days after cocaine use, without a diagnosis of hypertension; home readings plannedactiveconfirmed R03.0S — Synthetic presenting finding; resolved into a diagnosis of hypertension at four weeks.
Financial insecurity: years of tax debt from his time as a well-paid athlete, now settled, left him with no savings; irregular income from paid appearances; worry about money keeps him awakeactiveconfirmed Z59.86S — Synthetic social need anchored to his documented tax debt.

Assessment and Plan

Protocol monitoring: items the monitoring protocol calls for at this visit. [S]

DomainMeasureIntervalStatusDetail
Self-managementCocaine use since the last visit (his own account), cravings and triggersEvery visitCompleted todayNo cocaine for ten days; cravings in the evenings
LaboratoryUrine drug tests in contingency management, with fentanyl, and prize draws for negative resultsTwice weekly for twelve weeks, then at visitsCompleted todayIntake test positive for cocaine, negative for fentanyl; contingency management begins today with the first test, negative
ExaminationPsychotic symptoms, insight and sleepEvery visitCompleted todayPersecutory beliefs less firmly held; no hallucinations; sleep about four hours
Medication safetyAntipsychotic safety: weight, blood pressure, akathisia (Barnes scale) and abnormal movements (AIMS)Weight and akathisia at every visit while on treatment; AIMS at baseline and every six monthsCompleted todayBaseline before aripiprazole: weight 101.0 kg, BMI 28.9, blood pressure 148/94; AIMS 0; no akathisia; QTc 436 ms at intake
LaboratoryFasting glucose or hemoglobin A1c and lipids on an antipsychoticBaseline, at four months, then yearlyCompleted todayBaseline fasting lipids today: total cholesterol 204, HDL 44, LDL 128, triglycerides 160 mg/dL; hemoglobin A1c 5.5% at intake
ExaminationCognitive screen (MoCA)At baseline and again once he is well and off cocaineUp to dateMoCA 25 at intake during symptoms and short sleep; repeat once he is well
ImagingBrain MRI for new psychotic symptoms after age 50Once, at presentationCompleted todayNo contusion, microbleeds or mass; brain volume normal for age
ExaminationBlood pressure in clinic and at homeEvery visit; home readings before diagnosis and after each changeOrdered148/94 mmHg; home readings planned before the four-week visit
SurveySuicide and violence risk review, safety plan and the 988 Suicide & Crisis LifelineEvery visitCompleted todayNo thoughts of suicide or of harming anyone; no firearms; 988 saved in his phone
Medication safetyNaloxone and fentanyl test strips on handEvery visitCompleted todayNaloxone and test strips at home; he knows how to use them
SurveyDepression (PHQ-9) and anxiety (GAD-7)At baseline and every four weeks while in treatmentUp to datePHQ-9 8 and GAD-7 9 at intake; repeat at four weeks
Self-managementCognitive behavioral therapyWeeklyOrderedFirst session booked this week
Self-managementFinances, social work and taxpayer servicesEvery visitOrderedSocial work appointment next week
Self-managementFamily involvement, only with his consentEvery visitCompleted todayHe does not want family contacted for now; respected
ReferralAddiction psychiatry consultationAt the start of treatmentCompleted todaySeen by Dr. Featherstone-Ibe today

Goal progress:

Guideline basis: The ASAM/AAAP Clinical Practice Guideline on the Management of Stimulant Use Disorder (2023); The American Psychiatric Association Practice Guideline for the Treatment of Patients With Schizophrenia (2020); Treatment for Stimulant Use Disorders (Treatment Improvement Protocol 33, updated 2021) (2021); National Institute of Neurological Disorders and Stroke Consensus Diagnostic Criteria for Traumatic Encephalopathy Syndrome (2021); VA/DoD Clinical Practice Guideline for Assessment and Management of Patients at Risk for Suicide (2024); CMID: Clinical Monitoring Intelligence Database, hypertension and depression, bipolar, and mood disorders monographs (2026)

Follow-up: Four-week review in three weeks with home blood pressure readings, the PHQ-9 and GAD-7. Contingency management twice weekly and therapy weekly. Call the clinic or 988, or go to the emergency department, for any of the urgent signs on his plan. Next scheduled visit 1969-08-10: four-week review: psychotic symptoms, urine tests, blood pressure and a diagnosis of hypertension. [S]